Cas 878206-29-2,[4-chloro-3-[[(tricyclo[3.3.1.1<sup>3,7</sup>]dec-1-ylmethyl)amino]carbonyl]phenyl]boronic acid

878206-29-2

Post Buying Request

Basic information

Product Name: [4-chloro-3-[[(tricyclo[3.3.1.1^3,7]dec-1-ylmethyl)amino]carbonyl]phenyl]boronic acid
Synonyms: [4-chloro-3-[[(tricyclo[3.3.1.1^3,7]dec-1-ylmethyl)amino]carbonyl]phenyl]boronic acid
CAS NO:878206-29-2
Molecular Formula:
Molecular Weight: 347.65
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: [4-chloro-3-[[(tricyclo[3.3.1.1^3,7]dec-1-ylmethyl)amino]carbonyl]phenyl]boronic acid(CAS DataBase Reference)
NIST Chemistry Reference: [4-chloro-3-[[(tricyclo[3.3.1.1^3,7]dec-1-ylmethyl)amino]carbonyl]phenyl]boronic acid(878206-29-2)
EPA Substance Registry System: [4-chloro-3-[[(tricyclo[3.3.1.1^3,7]dec-1-ylmethyl)amino]carbonyl]phenyl]boronic acid(878206-29-2)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 878206-29-2(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

878206-29-2 Suppliers

Recommended suppliers

878206-29-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 878206-29-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,8,2,0 and 6 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 878206-29:
(8*8)+(7*7)+(6*8)+(5*2)+(4*0)+(3*6)+(2*2)+(1*9)=202
202 % 10 = 2
So 878206-29-2 is a valid CAS Registry Number.

878206-29-2Upstream product

301672-80-0 5-bromo-2-chloro-N-(tricyclo[3.3.1.1^3,7]dec-1-ylmethyl)benzamide

878206-29-2Downstream Products

878206-29-2Relevant academic research and scientific papers

ADAMANTYL DERIVATES AS P2X7 RECEPTOR ANTAGONISTS

-

Page/Page column 53, (2010/10/20)

The invention provides compounds of formula (I) pharmaceutically acceptable salt or solvate thereof, in which R1, A1, m and A are as defined in the specification; a process for their preparation; pharmaceutical compositions containin

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 878206-29-2